Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
2.360
-2.670 (-53.08%)
At close: Aug 1, 2025, 4:00 PM
3.970
+1.610 (68.22%)
After-hours: Aug 1, 2025, 7:59 PM EDT

Heartland Financial USA Income Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22
Selling, General & Admin
3.321.81.631.72
Research & Development
0.340.951.610.14
Operating Expenses
3.662.753.231.86
Operating Income
-3.66-2.75-3.23-1.86
Interest Expense
-0.01-0.05--
Interest & Investment Income
0.100-
Currency Exchange Gain (Loss)
-0.01-00.03-0
Other Non Operating Income (Expenses)
0.510.57--
EBT Excluding Unusual Items
-3.07-2.23-3.21-1.86
Gain (Loss) on Sale of Investments
0.02---
Other Unusual Items
4.06-48.93--
Pretax Income
1.01-51.16-3.21-1.86
Net Income
1.01-51.16-3.21-1.86
Net Income to Common
1.01-51.16-3.21-1.86
Shares Outstanding (Basic)
00--
Shares Outstanding (Diluted)
00--
Shares Change (YoY)
122.15%---
EPS (Basic)
41.77-4692.20--
EPS (Diluted)
41.77-4692.20--
Free Cash Flow
-3.74-2.95-1.59-1.4
Free Cash Flow Per Share
-154.58-270.67--
EBITDA
-3.66-2.75--
D&A For EBITDA
00--
EBIT
-3.66-2.75-3.23-1.86
Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q